Translational Programs in Lung Diseases (P01)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) invites submission of Program Project (P01) applications from institutions/organizations that will perform collaborative, translational research with the goal of using mechanistic research as the basis for the rational design of clinical applications to improve prevention, diagnosis and/or treatment of lung diseases and sleep disorders.


  • Letters of Intent Receipt Date(s): 30 days prior to the application due date
  • Application Receipt/Submission Date(s): September 22, 2014; May 19, 2015; September 22, 2015; May 19, 2016; September 22, 2016; May 19, 2017, by 5:00 PM local time of applicant organization.

PAR-14-245 Expiration Date: New Date September 23, 2016 per issuance of NOT-HL-16-308. (Original Expiration Date: May 20, 2017)

The purpose of this Notice is to announce a change in application due dates and the type of applications eligible to apply for PAR-14-245 "Translational Programs in Lung Diseases (P01)". Effective immediately, the May 19, 2016 and May 19, 2017 application due dates are eliminated. Only Renewal applications, both new and resubmissions, will be accepted on the September 22, 2016 due date. 

Agency Website



Amount Description

Application budgets are not limited but it is recommended that applicants not request a budget of more than $1.75 million per year direct costs (exclusive of F&A costs associated with consortia) for a maximum of $8.75 million directs costs over a five-year project period.

Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

September 22, 2016